The consumption of yogurt has been associated with a reduced incidence of colon cancer in population groups. Bioactive peptides produced during bacterial fermentation may alter the risk of colon cancer via modification of cell proliferation in the colon. Using our previously described cell culture model system, we have isolated a yogurt fraction that decreases cell proliferation. Yogurt was fractionated using 10,000-and 500-Da membrane dialysis. When the yogurt fraction was incubated with IEC-6 or Caco-2 cells, cell division was decreased compared with control treatments, as determined by thymidine incorporation. Cell division was not inhibited in response to a similarly produced milk fraction or in response to solutions of lactic acid. The determination of cell kinetics by flow cytometry revealed a decrease in the number of cells in the initial growth phase in response to the yogurt fraction for the IEC-6 cells, but not the Caco-2 cells. a-Lactalbumin inhibited cell division of both cell lines, but b-casein did not. (
INTRODUCTION
Recent epidemiological evidence suggests that regular consumption of fermented milk products such as yogurt may be protective against some forms of cancer (14, 18) . Attempts to identify the components of yogurt that provide this protection have relied upon animal and bacterial assays ( 1 ) . An anionic fraction that was obtained from yogurt decreased the growth of Ehrlich ascites in mice ( 2 ) . Antimutagenicity increased 2.5-fold with acetone extracts of yogurt compared with antimutagenicity of an acetone extract of unfermented milk in the Ames test (17) . These systems have two limitations. First, the direct effects of these fermented milks on colon cells could not be determined. Second, the procedures used to obtain the yogurt fractions (acetone extraction or ion-exchange chromatography) may have modified the naturally occurring components and produced artifactual results.
One important physiochemical change occurring in yogurt during fermentation is the mild proteolysis of casein. Strains of lactic acid bacteria generate distinct populations of peptides, and these peptides provide a growth stimulus for the bacteria themselves (20) . Peptide fractions obtained from enzymatic hydrolysis of caseins have been shown to have other physiological effects, such as opioid activity and immunomodulating functions (16) . Casein phosphopeptides appear to survive gastrointestinal digestion and have been recovered in feces (16) . Therefore, the peptides generated by the bacteria found in yogurt possibly may affect colon cells directly. Compounds other than peptides may also be produced by the bacterial fermentation.
We previously reported a cell culture model system in which two mammalian intestinal cell lines were used to observe the direct effects of fermented milk (15) . Changes in cell division and cellular kinetics of the two cell lines were observed in response to exposure to the supernatant of yogurt fermented with Streptococcus thermophilus and Lactobacillus bulgaricus. To examine further the components in yogurt that convey these effects on the cultured cells, we developed a processs of membrane dialysis to separate fractions from yogurt and milk. The main objective was to develop a process that did not employ heat or chemical additions in order to preserve the biological activity of the separated compounds. Both IEC-6 and Caco-2 cells were exposed to the separated fractions, and changes in cell proliferation were determined using [ 3 H]thymidine uptake and cell cycle analysis by flow cytometry. Appropriate controls were developed, including uninoculated milk and lactic acid solutions. Also, the response of the cells to two bovine proteins, a-LA and b-CN, was determined.
MATERIALS AND METHODS
Reconstituted nonfat milk (Carnation Co., Los Angeles, CA) was heated at 85°C for 30 min and then cooled to 42°C to reduce bacterial contamination. The milk was inoculated with commercial yogurt starter cultures (Rhône-Poulenc Inc., Marschall Products, Madison, WI) and incubated for 3 h at 42°C in a water bath. The incubation period was adequate to produce a sample that had a pH of 5.5, but did not induce coagulation, which occurs at pH 4.6. The yogurt was then divided into aliquots and stored at -20°C. To mimic the effects of lactic acid on the proteins without fermentation, a control was made by adding DL-lactic acid (Fisher Scientific, St. Louis, MO) to reconstituted nonfat milk prepared as just described. The concentrations of L(+)-and D(-)-lactic acid in the fractions were determined by spectrophotometric methods (Sigma Chemical Co., St. Louis, MO and Boehringer Mannheim, Indianapolis, IN). Lactic acid, at the same concentration measured in the yogurt, was added to the nonfat milk at 0°C with constant stirring, and the mixture was held at 25°C for 15 min. The acidified milk was then divided into aliquots and stored at -20°C.
Yogurt and acidified milk aliquots were thawed and then dialyzed at 4°C against 100 ml of ultrapure water (Milli-Q, Millipore; Bedford, MA) using 10-kDa cellulose ester membrane discs (Spectra/ Por ® ; Spectrum Medical, Houston, TX) with a 10-ml macrodialyzer (Spectra/Por ® CE; Spectrum Medical) for 17 h. The dialysate was then lyophilized and resuspended in 4 ml of ultrapure water. Because the volumes that could be obtained from the dialysis system were limited, multiple dialysates of yogurt and acidified milk were produced and pooled. To remove lactic acid, the pooled fractions (15 ml) were dialyzed at 4°C against 1000 ml of ultrapure water with 500-Da cellulose ester tubing (Spectra/Por ® CE) for 24 h with six changes of water and constant stirring. Despite repeated attempts to dialyze lactic acid from the yogurt, the lactic acid content of the yogurt dialysate remained higher (59.8 mg/dl) than that of the acidified milk ( 9 mg/dl). Therefore, to test whether differences in response of the cells to yogurt and acidified milk could be due to the differences in lactic acid content, two additional controls were included. Aqueous solutions of lactic acid were prepared that were equivalent to the amount of lactic acid that was present in yogurt or acidified milk.
The protein content of the fractions was assayed using the Bio-Rad method (Bio-Rad Laboratories, Hercules, CA) with BSA as the standard. To compare the responses of the cells to previously studied milk proteins, a-LA and b-CN (Sigma Chemical Co.) were also tested.
The IEC-6 cells ( 1 9 ) were maintained in Dulbecco's minimal essential medium supplemented with 10% fetal bovine serum (Sigma Chemical Co.) and 1% L-glutamine. The Caco-2 cells ( 1 0 ) were maintained in Eagle's minimal essential medium supplemented with 15% serum, nonessential amino acids, sodium pyruvate, L-glutamine, and 1 M HEPES (the media and supplements were obtained from Gibco BRL Life Technologies, Grand Island, NY). Cells and media were routinely tested for mycoplasma contamination. The cells were maintained in a humidified atmosphere of 95% O 2 and 5% CO 2 and subdivided weekly. The cells were plated onto 24-well plates or 35-mm dishes (Becton Dickinson, Franklin Lakes, NJ) at densities of 20,000 and 30,000 cells/ml for IEC-6 and Caco-2 cells, respectively. After plating, the cells were incubated for 48 h to obtain 70 to 75% confluency. Media were aspirated, and the cell monolayers were washed twice with PBS and then were incubated with serum-free media for 2 h. The yogurt, acidified milk, and aqueous solutions of lactic acid were diluted 30-fold into cell culture media containing 2% serum. Aqueous solutions of 2.5 mg/ml of b-CN and a-LA were also diluted 30-fold into media with 2% serum. Cell monolayers were washed once with PBS, 1 ml of the media solution per well was added, and the cells were placed in the CO 2 incubator for 6 h.
For thymidine incorporation, the media were aspirated, and the cells were washed with PBS. Cells were then incubated at 37°C for 30 min with 1 ml of medium containing 10% (IEC-6) or 15% (Caco-2) serum to which 100,000 cpm [methyl-3 H]thymidine ( 1 mCi/ml; Amersham, Arlington Heights, IL) was added. Cells were washed twice with PBS and then harvested with 1 N NaOH. The amount of radioisotope incorporated was measured by scintillation counting (Pico Fluor™ scintillation solution in a Packard scintillation counter; Packard Instruments, Downers Grove, IL).
For analysis of cell kinetics, following the 6-h exposure to the test solutions, cells were harvested with 0.5% trypsin in PBS into polystyrene tubes and centrifuged at 1250 × g for 10 min. The cells were prepared for acridine orange staining as described previously (15) . Acridine orange was excited at 480 nm, and two emission wavelengths (530 and 640 nm) were measured. A flow cytometer was used to count Peptide patterns of the yogurt and acidified milk fractions were observed using 10 to 20% gradient acrylamide gels. The samples were dissolved in Laemmli's buffer, heated, and centrifuged prior to loading. The gels were run at constant voltage (75 V ) for 15 min and then at constant current (25 mA) for 45 to 60 min. Bands were visualized by silver staining (BioRad Laboratories, Hercules, CA).
Data analysis was performed using SAS/STAT ® (21). Analysis of variance with the least squares mean separation method, with a priori significance of P < 0.05, was used to determine the statistical significance of the data (21) .
RESULTS AND DISCUSSION
The peptide composition of the yogurt and acidified milk fractions were distinctly different when examined by SDS-PAGE (Figure 1) . The milk fraction (lane 8 ) did not contain the bands between 6.5 and 14 kDa that were present in the yogurt fraction (lane 7). Furthermore, the yogurt fraction contained more protein, 3.4 mg/ml, than did the milk fraction, 1.5 mg/ ml, as determined by the Bio-Rad method. Therefore, the dialysis system retained the peptide products of the bacterial fermentation.
Thymidine uptake of both cell lines was lower ( P < 0.001) following exposure to the yogurt fraction than was that of the 2% serum control (Figures 2 and 3 ).
Thymidine uptake in the two cell lines was not affected by exposure to the acifidied milk fraction. The decrease in thymidine incorporation with exposure to the yogurt fraction, but not the aqueous lactic acid control, suggests that the effects of yogurt fraction were not caused by lactic acid. A decrease ( P < 0.001) in thymidine incorporation in response to a-LA was also observed in both cell lines, but incorporation was inhibited in the Caco-2 cells only by b-CN. A recent study ( 1 2 ) showed that the multimeric a-LA generated during cation-exchange chromatography at a concentration of 10 mg/ml was cytotoxic to human colon carcinoma cell lines such as Caco-2 and HT-29 cells but spared mature epithelial cells. An apoptotic effect of this multimeric a-LA on transformed cells was suggested; however, commercial bovine a-LA was without effect on the cells. In contrast, our results indicate that commercial bovine a-LA at a lower concentration decreased cell proliferation in both cell lines. The b-CN decreased thymidine uptake in the Caco-2, but not in the IEC-6 cells, although a decrease in cell proliferation did occur in the IEC-6 cells with 20 mg of b-CN/ml (data not shown). These findings suggest that these two proteins have different effects on cell proliferation and that modification of proteins during processing can alter bioactivity.
The majority of the cells of both cell lines were in the pre-DNA synthetic phase ( G 1 ) of the cell cycle (Table 1) , indicating rapid cell division. The number of cells in the combined DNA synthesis and mitotic TABLE 1. Mean number 1 of IEC-6 or Caco-2 cells in cell cycle phases following exposure to the test solutions determined by acridine orange staining with flow cytometry. a,b,c Means within a column with no common superscripts differ ( P < 0.001). 1 A total of 10,000 cells per sample were counted. Data represent the mean number of cells in each phase of the cell cycle. Data represent two experiments with six replicates per test solution in each experiment. 2 Test solutions: 2% serum = Dulbecco's minimal essential medium (IEC-6) or Eagle's minimal essential medium (Caco-2) with 2% fetal bovine serum to which ultrapure water was added; YD and YD-L = yogurt and aqueous lactic acid control, respectively; and MD and MD-L = acidified milk and aqueous lactic acid control, respectively. 3 Initial growth phase prior to DNA synthesis. 4 Combined DNA synthesis and mitotic phases. phases ( S + G 2 /M) was greater ( P < 0.001) in the IEC-6 cells that were exposed to either the yogurt fraction or a-LA than was the number in the 2% serum control. No differences ( P < 0.05) in the distribution of the cell cycle were observed when IEC-6 cells were incubated with the acidified milk fraction, lactic acid controls, or b-CN. For Caco-2 cells, the number of cells in the G 1 phase increased ( P < 0.001) in response to the acidified milk fraction, although no other treatment affected the cell cycle distribution.
In a previous report (15) , we established a cell culture model using the IEC-6 and Caco-2 cells to determine the biological effects of yogurt supernatant on cell proliferation. Thymidine uptake decreased with IEC-6 cells, but increased with Caco-2 cells, following exposure to the yogurt supernatant. Also, IEC-6 cells had more cells in the G 1 phase than in S + G 2 /M phases in response to the yogurt supernatant. In the present study, a more purified yogurt fraction caused decreased thymidine incorporation but, paradoxically, increased the S + G 2 /M fraction in IEC-6 cells. These effects were not observed in cells that were exposed to the acidified milk fraction or to lactic acid controls, thus suggesting the presence of a unique and functional component in the yogurt fraction. Based on previous studies (7, 15) that have corroborated decreased thymidine uptake with an increased G 1 phase, the present results were probably due to the blockage of the cells in S + G 2 /M phases, thus preventing cells from entering G 1 and preventing further proliferation. It has also been documented ( 8 ) that, with 30 min of exposure to labeled nucleosides, only cells in the S phase incorporate thymidine. Thus, decreased thymidine uptake suggests that fewer cells have synthesized DNA and incorporated the radiolabeled nucleoside. Therefore, exposure of the cells to the yogurt fraction may have produced a population of cells that were blocked in the proliferative phase ( S + G 2 /M) and did not synthesize DNA.
Journal of Dairy Science Vol. 80, No. 10, 1997 The decreased thymidine uptake in response to the yogurt fraction by Caco-2 cells and the lack of differences in cell kinetics suggest that Caco-2 cells were affected differently by the yogurt fraction than were the IEC-6 cells. Decreased growth in response to fermented milk has been reported for HT-29 cells, a human colon carcinoma cell line similar to the Caco-2 cells ( 3 ) . The HT-29 cells were continuously exposed to milk fermented with yogurt cultures of S. thermophilus and L. bulgaricus. The HT-29 cells also showed an increase in dipeptidyl peptidase IV, an enterocytic differentiation marker, which suggests that these cells may have been differentiated in response to the fermented milk with arrested cell division ( 3 ) .
Our results suggest protective, antiproliferative effects of the yogurt fraction on cultured mammalian intestinal cells. Previous studies (2, 4, 5, 9, 11, 13) have suggested protective activity of peptides originating either from the bacterial cell wall or by hydrolysis products of the lactic acid bacteria. The effects of the yogurt fraction obtained by dialysis in our study positively confirms the presence of the putative biologically active compounds that caused a significant decrease in cellular proliferation in the cultured cells. The absence of these responses in the milk fraction suggests production of certain bioactive compounds from the milk during the process of fermentation by S. thermophilus and L.bulgaricus. Identification of the chemical composition of the compounds is currently under investigation.
CONCLUSIONS
A yogurt fraction that had been generated by membrane dialysis and filtration demonstrated an antiproliferative effect on cultured mammalian intestinal cells. Thymidine incorporation used in conjunction with flow cytometry provides a powerful tool for understanding the changes in cellular kinetics in screening compounds with biological potency (antiproliferative and antineoplastic effects). Analysis of the direct responses to these fractions in cell culture should provide information that may lead to future exploration of the pharmacological and therapeutic uses of these compounds.
